Analytical Data
-
基因名
CCNJ
- Application
-
别名
bA690P14.1; Ccnj; CCNJ_HUMAN; Cyclin J; Cyclin-J
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q5T5M9
-
表达区间
1-372aa
-
氨基酸序列
MELEGQWWRGQLAADIHQALRYKELKLPSYKGQSPQLSLRRYFADLIAIVSNRFTLCPSARHLAVYLLDLFMDRYDISIQQLHLVALSCLLLASKFEEKEDSVPKLEQLNSLGCMTNMNLVLTKQNLLHMELLLLETFQWNLCLPTAAHFIEYYLSEAVHETDLHDGWPMICLEKTKLYMAKYADYFLEVSLQVAAACVASSRIILRLSPTWPTRLHRLTAYSWDFLVQCIERLLIAHDNDVKEANKQRGQAGPQSAQLSVFQTASQPSRPVHFQQPQYLHQTHQTSLQYRHPTSEQPSCQQIVSTTHTSSYTLQTCPAGFQTSVQGLGHMQTGVGMSLAIPVEVKPCLSVSYNRSYQINEHYPCITPCFER
-
分子量
66.66 KDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CCNJ, also known as cyclin J, is a member of the cyclin family that plays a crucial role in cell cycle regulation. Research on CCNJ has gained significance due to its involvement in various cellular processes, including cell proliferation, differentiation, and apoptosis. Alterations in CCNJ expression and function have been linked to several diseases, particularly cancer, where dysregulation of cell cycle control is a hallmark. Investigating recombinant CCNJ proteins offers insights into its structural and functional properties, enabling a better understanding of its role in normal cellular mechanisms and disease states. Additionally, recombinant protein studies provide a platform for exploring potential therapeutic targets and strategies, as manipulating CCNJ pathways may enhance treatment outcomes in cancer and other proliferative disorders. As such, the study of CCNJ through recombinant technology not only enriches our understanding of cell cycle dynamics but also paves the way for innovative approaches to combat diseases associated with its dysfunction.
